UMaine biotech start-up Neuright to be featured in March 15 Innovation Blender
Kristy Townsend, University of Maine alumna and former faculty member, and cofounder of Neuright Inc., will lead a discussion, “Neuright Inc. Tackles Peripheral Neuropathy — Catch It Early, Fix It Fast,” as part of the Innovation Blender series sponsored by MaineHealth Innovation and The Roux Institute. The event is noon–12:45 p.m. EST March 15 via Zoom. Registration is online.
Neuright is a UMaine biotech start-up and academic spin-out company that has commercialized a new patent-pending theragnostic medical device for peripheral neuropathy, a condition of nerve death in tissues and organs that is common with aging, diabetes, and more than 30 other diseases and disorders. Founders Townsend and former UMaine graduate student Magdalena Blaszkiewicz have recently partnered with neurologists at The Ohio State University to begin comprehensive first-in-human testing comparing healthy and neuropathic patients and have begun developing a diagnostic algorithm from their nerve activity data. Learn more about neurightlabs.com.